علاج سرطان عنق الرحم في المرحلة الأولية IVB وفق FIGO أو المرض المتكرر/المستمر مع حالة أداء أقل من 2

References

1. Palliative chemotherapy with the aim of relieving symptoms and improving quality of life is indicated if the patient has a PS < 2 and no formal contraindications.
2. Patients with primary stage IVB or recurrent/persistent, good PS (0 or 1) and measurable disease were randomised to paclitaxel–cisplatin or paclitaxel–topotecan, both with or without bevacizumab.
3. In patients progressing following first-line therapy, different cytostatic agents, including vinorelbine, topotecan, gemcitabine or nanoparticle albumin-bound paclitaxel have been evaluated (Table 4).